INS and obesity disorder: Regardless, the placenta remains normosensitive to insulin in women with obesity, thus, increased placental insulin activation, along with leptin, has been shown to promote mTOR signaling leading to increased glucose and amino acid transport across the placental barrier and fetal overgrowth (81).